Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT plus Sintilimab and Fruquintinib in Advanced Colorectal Cancer
NCT05279677Phase 2Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Aug 2022
- Primary completion
- Oct 2023
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of Fecal Microbiota Transplantation Capsule in colorectal cancer (CRC), sponsored by Chinese Academy of Medical Sciences. Status: unknown.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT05279677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05279677.